£13.46

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Nursing

Price data last checked 14 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Pricier than usual. £1 more than the 30-day average — we'd wait.

£13 today · 30-day average £12 · all-time low £11

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 77 days • 10 price levels

Days at Price

Current Price

Price Analysis

Most common price: £11 (11 days, 14.3%)

Price range: £11 - £53

Price levels: 10 different prices over 77 days

Description

The past quarter-century has seen tremendous progress in biomedical research, leading to increasing understanding of cancer, heart disease, diabetes, and other devastating diseases. The Nation has led the world in such progress, due in significant part to wise investments by the Federal Government in basic biomedical research. These breakthroughs are beginning to pay off in terms of new therapies for American patients. Still, the pace of new therapeutic development has not kept up with the explosion in scientific knowledge. The number of novel drugs has remained constant for several decades, even though R&D budgets have substantially increased. This situation poses an increasing challenge for ensuring the creation of innovative therapies for patients and throughout the biomedical ecosystem. This book examines the efforts being made to double over the next decade, the rate of invention of innovative new medicines for patients, while increasing drug safety, in the hopes that these actions will advance the health of Americans, as well as provide economic growth for the Nation.

Product Specifications

Format: hardcover
ASIN: 1624179096
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Nursing
Domain: Amazon UK
Release Date: 18 March 2013
Listed Since: 27 December 2012

Barcode

No barcode data available

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Pricier than usual. £1 more than the 30-day average — we'd wait.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)

Social Aspects of Drug Discovery, Development and Commercialization

Research and Development in the Pharmaceutical Industry

Artificial Intelligence for Drug Product Lifecycle Applications

Drugs: From Discovery to Approval

The Science and Business of Drug Discovery: Demystifying the Jargon

Fundamentals of Medicinal Chemistry

Drug Approval and Evaluation, Delivery and Control: Approval & Evaluation, Delivery & Control

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Springer - Innovation and Marketing in Pharmaceutical Industry

Pharmaceutical Product Development: Insights Into Pharmaceutical Processes, Management and Regulatory Affairs

The Ups and Downs in Drug Design: Adventures in Medicinal Chemistry

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

The Thriving Biopharma Business: How to Unlock Value and Drive Success in Biotech and Pharma

The Science and Business of Drug Discovery: Demystifying the Jargon

The Science and Business of Drug Discovery: Demystifying the Jargon

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)